Patients Now have the Freedom to Choose Stem Cell TreatmentJune 28, 2017
For decades, tens of thousands of patients around the world have reported positive results from stem cell therapy to treat a wide range of ailments. In certain areas of medicine, such as plastic and reconstructive surgery and orthopedics, the use of adult stem cells is an accepted practice, often touted by surgeons for their curative properties. Yet, testimonials from stem cell patients for treatment of maladies such as Parkinson’s Disease, Rheumatoid Arthritis, Multiple Sclerosis and other debilitating illness are typically discounted by the FDA and medical professionals committed resolutely to evidence-based science.
One by one, the states of this nation have listened to the voices of patients and enacted legislation to empower them to receive stem cell therapy. In passing House Bill 810, Texas has become the latest to allow patients access to this Right to Try innovative form of therapy for those suffering with debilitating and incurable illnesses.
Rita Alexander, Chief Administrative Officer at StemGenex Medical Group in La Jolla, Ca applauds Texas for this patient-centered legislation and Republican State Rep. Drew Springer, R-Muenster, who passionately advocated for this bill. Over the past three years, Right to Try advocates in 33 states now have helped enact legislation to eliminate obstacles for terminally ill patients seeking treatments that may not be approved by the FDA. Those advocates are showing considerable momentum in the remaining 17 states, potentially expediting clinical therapies for patients who have limited options.
“Freedom to choose stem cell therapy is wonderful news for thousands of patients who have walked through the doors at StemGenex, seeking hope and help, often as a last option after failure of conventional medical treatments,” says Alexander.
In a move that was seen by some as a response to Right to Try laws, the 21st Century Cures Act, a landmark piece of legislation focused on medical innovation and medical research, was signed into law by President Obama. This Act provides the FDA with the flexibility to accelerate how it evaluates regenerative medicine treatments, such as stem cell therapies, while maintaining its high standards of safety and efficacy.
“What I personally witnessed before the start of StemGenex were patients who had exhausted conventional medical treatments but wanted to try alternative therapies,” stated Alexander. “I was one of them, suffering from severe Rheumatoid Arthritis. I had only three options; I could seek a clinical trial, travel outside of the U.S. to try alternative therapies such as stem cell treatment or petition the FDA for access to drugs under the agency’s “expanded access,” or “compassionate use” program. Now, new state laws, built on model legislation from the Goldwater Institute in Arizona, will allow doctors and patients to make their own informed decisions on treatments that have cleared the safety phase of FDA testing.”
“We’re on the cusp of a major change on how patients can access stem cell therapy,” adds Alexander. “Today, new treatments and advances in stem cell research are giving new hope to people affected by a wide range of autoimmune and degenerative illnesses.
StemGenex Medical Group is proud to offer the highest quality of care and to potentially help those with unmet clinical needs improve their quality of life.”
To find out if you are a candidate for stem cell treatment, Call (855) 742-7836 to speak with a Patient Advocate or Visit www.StemGenex.com.